
In November 2024, the Department of Labor (DOL) issued an advisory opinion confirming the Family Medical Leave Act (FMLA) could…
In November 2024, the Department of Labor (DOL) issued an advisory opinion confirming the Family Medical Leave Act (FMLA) could…
A report by the Brown University Center for Advancing Health Policy through Research (CAHPR) highlights that Medicare Advantage (MA) plans,…
On January 14, 2024, the Federal Trade Commission (FTC) released its second report investigating the pharmacy benefit manager (PBM) industry.…
In December 2024, the Bipartisan Artificial Intelligence (AI) Task Force released the “Bipartisan House Task Force Report on Artificial Intelligence.”…
The 119th, Congress faces critical policy decisions to address rising federal deficits, which are projected by the Congressional Budget Office…
The U.S. Drug Enforcement Administration (DEA) has extended the temporary telemedicine flexibilities allowing providers to prescribe controlled substances without an…
The Coalition for Health AI (CHAI), a group of stakeholders that collaborate to drive the development, evaluation, and appropriate use…
On November 8, 2024, Aimed Alliance submitted feedback to the Maryland Prescription Drug Affordability Board regarding its updated rules for…
Currently, Medicare coverage for anti-obesity medications is limited to indications for diabetes and cardiovascular disease. Policymakers, however, have proposed expanding…
On October 10, 2024, the National AI Advisory Committee released its draft transition plan for the incoming administration. The…